Explore MyBioSource's premium PCR kits for disease detection and genetic research, offering fast, accurate results for oncology, infectious diseases, and more.
Point-of-care PCR testing for STIs in the ED reduced length of stay and improved antibiotic stewardship compared with central laboratory testing.
Currently available human papillomavirus (HPV) detection devices are expensive, requiring a continuous power supply, high-priced reagents, skilled laboratory personnel, and infrastructure. These make ...
A polymerase chain reaction (PCR) test detects genetic material from a pathogen or abnormal cell sample. Ways of collecting samples include a nasal swab, a saliva swab, or taking a sample of blood.
Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...
As the United States enters its fourth month of response to the COVID-19 crisis, many are pointing to the testing of people potentially infected with the disease as the key to effective mitigation of ...
Zacks Investment Research on MSN
CODX shares dip despite Australian patent grant for Co-Dx PCR platform
CoDiagnostics CODX recently announced that the Australian Patent Office has granted a patent covering its new Co-Dx PCR ...
Amerigo Scientific launches its isothermal amplification instrument range to overcome the limitations of current nucleic acid amplification technologies.
The Australian patent represents the first patent granted for the Company's new point-of-care testing platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback